Olivia Teseniar was part of Moderna’s trial. After 2 yrs of serious adverse reactions she now has T-cell lymphoma and leukaemia. Her issues were omitted from Moderna’s submission to the FDA. She recorded her last meeting with the Principal Investigator of the trial.